drug combination
452 articles
My Two-Year Journey with Pancreatic Cancer
When filmmaker Glen Trotiner was diagnosed with pancreatic cancer, he learned a new meaning for “treatment.”
An Immunotherapy Game Changer
Immunotherapy with Keytruda (pembrolizumab) is approved for use in cancer patients with certain genetic defects in their tumors.
Multi-Site Precision Promise Study Opens
Dr. Vincent Picozzi explains how Precision Promise clinical trial will use a personalized approach for pancreatic cancer patients.
Potential Therapy Takes a Two-Prong Attack on Pancreatic Cancer
With a focus on targeting cell metabolism, Dr. Anup Kasi leads a clinical trial of a new agent in combination with gemcitabine.
Targeting a KRAS Variant in Advanced Pancreatic Cancer
Researchers are testing a new drug that targets KRAS variant G12D in conjunction with different chemotherapies.
The Pancreatic Standard of Care is No Longer So Standard
Do you want to understand more about how your doctor chooses your treatments? Learn about the standard of care for pancreatic cancer.
New Trial to Find Biomarkers to Guide Treatment
Drs. Jennifer Knox and Elizabeth Jaffee lead the PASS-01 trial using biomarkers and other measures to choose individualized treatment.
Choosing the Strongest Chemotherapy for Pancreatic Cancer
Miriam Hermosa decided to take advantage of her relatively good health and try pancreatic cancer treatment with FOLFIRINOX to get more time with her family.
Testing Vitamin C as a Cancer Killer
Lewis Cantley’s team is starting clinical trials of vitamin C to gain more information about its role in stopping cancer.
Inhibiting Cell Division With Alternating Electric Fields
Dr. Andrew Coveler explains how electric fields are being used to disrupt pancreatic cancer cell division, to make tumors more removable.
Enhancing Standard Chemotherapy in Metastatic Pancreatic Cancer
Researchers are testing a new kinase inhibitor as a way to make standard chemotherapy more effective against advanced pancreatic cancer.
A Potential Role for PARP Inhibitors in Pancreatic Cancer
Dr. Michael Pishvaian leads research into the possible role of PARP inhibitors in treating pancreatic cancer patients with certain genetic mutations.
Finding a Clinical Trial
Let’s Win’s Trial Finder Clinical trials are important to consider for pancreatic cancer patients at all stages of the disease. Trials provide access to cutting-edge treatments not yet widely available, offering hope and potentially better outcomes. Studies are taking place at numerous locations across the United States, making participation more accessible than ever. Let’s Win […]
The American Association for Cancer Research (AACR) Virtual Special Conference: Pancreatic Cancer Day Two
Let’s Win and the Lustgarten Foundation bring you the highlights from Day Two of the AACR special conference on pancreatic cancer.
Forget Stages . . . Set Goals Instead!
After her pancreatic cancer diagnosis, Heather Sanderson set goals: surgery and then getting back to the gym.